Refine by
Parkinsons Disease Articles & Analysis
33 articles found
Consequently, the availability of these APIs has transformed the landscape of diabetes treatment, making it possible to tailor therapies to individual patient needs, thereby enhancing treatment outcomes and minimizing risks associated with elevated blood glucose levels. APIs for Parkinson's Disease: Continuing the Fight Against Neurodegeneration ...
Why Is NAD/NADH Analysis Important? Metabolic Health and Disease Research Alterations in NAD/NADH levels are associated with a wide range of diseases, including cancer, diabetes, neurodegenerative disorders (e.g., Alzheimer’s and Parkinson’s), and mitochondrial diseases. ...
This precision targeting is critical for treating diseases such as cancer, where minimizing damage to healthy tissues while aggressively targeting cancerous cells is paramount. ...
But when the time is right, it can hit the brakes on this growth, ensuring everything stays balanced and healthy. TNC Protein's Role in Disease Like many proteins, when TNC protein goes awry, disease can result. ...
Imagine a world where diseases like cancer, Alzheimer's, and Parkinson's could be diagnosed and treated at the molecular level, long before symptoms even appear. ...
ByMatexcel
Generates a valuable model for identifying new targets for neuro-regeneration as opposed to treatments limiting to symptomatic relief or delaying disease progression. Allows for future adaptation of technology for regenerative medicine and cell therapy in humans for the treatment of Parkinson's disease, Lou-Gehrig disease (ALS), ...
They contain a range of biomolecules, such as lipids, proteins, and nucleic acids. Cancer, Alzheimer's disease, and Parkinson's disease are just a few of the illnesses for which EVs can be used as biomarkers. ...
Drug-disease relationship analysis helps in unraveling these complexities by revealing the key players in disease progression. ...
These findings hold potential implications for Parkinson’s disease (PD), a neurodegenerative disorder that involves the PPN. ...
The findings could help develop new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's, and help understand how to keep the brain healthy as we age. ...
Accumulation of proteins usually leads to qualitative change in organism, thus causing tumorigenesis or disease. Therefore, quantification of proteins is significant for mechanism investigation. ...
People living with frontotemporal dementia, or FTD, are commonly misdiagnosed with psychiatric disorders or Alzheimer’s disease and other causes of dementia, such as Parkinson’s disease and vascular dementia. While frontotemporal dementia and Alzheimer’s disease can both cause dementia, there are distinct ...
These factors limit progress in developing new treatments for conditions like Alzheimer’s Disease, Parkinson’s Disease, Cancers, Autoimmune Disorders, and many others. ...
It’s reported that persistent activation of NF-κB can lead to chronic inflammation, such as rheumatoid arthritis, Parkinson's disease, and inflammatory bowel disease. However, NF-κB activation requires interactions with NF-κB essential modulators and kinase complexes. ...
Possible causes include musculoskeletal problems (such as leg weakness), neuromuscular problems (e.g., Parkinson’s disease) or sensory impairments (e.g., somatosensory deficit). ...
Precise Dosing for Maximum Outcomes There are many factors that impact the effectiveness of a treatment, such as when a patient takes their medication (before or after eating, the time of day, etc.) or how their body responds. Consider Parkinson’s Disease, for example. The timing of when someone takes their medication can fundamentally impact the ...
ByAiCure
The discovery could lead to better new treatments for neurological disorders such as anxiety, autism spectrum disorder, schizophrenia and Parkinson's disease. In determining the structure of this transporter, one of the smallest proteins ever made, researchers have opened up new avenues to improve drugs for a variety of debilitating diseases, ...
Alzheimer’s and Parkinson’s disease are both neurological diseases that cause progressive damage to the brain, resulting in a decline in neurocognitive function. While Parkinson’s disease is known for affecting movement and function and Alzheimer’s disease is known for ...
Parkinson’s disease is a progressive neurodegenerative disease that is most commonly known for affecting movement. ...
The relationship between lncRNAs and diseases is well established, especially in chronic disorders. However, cancer is one of the most intensively studied diseases associated with lncRNAs. ...